Welcome to ProAxsis
ProAxsis is developing a range of products for the capture, detection and measurement of active protease biomarkers of disease.
Our rapid and easy-to-use tests incorporate patented ProteaseTags®; smart molecules which trap an active protease within a complex biological sample and enable a visual readout of its presence. A number of active protease species have been extensively validated as biomarkers of disease activity in areas such as cancer and infection, in addition to respiratory diseases such as bronchiectasis, cystic fibrosis and COPD.
|CLINICAL/POINT OF CARE TESTS
CROSS PLATFORM TECHNOLOGY
SMART MOLECULE DESIGN
Dr David Ribeiro, CEO of ProAxsis, will be attending the Bio-Europe Spring meeting, taking place...
ProAxsis Limited (www.proaxsis.com) is further expanding its ProteaseTag® technology platform, via a p...
In a significant new study, a team at the University of Dundee has shown for the first time that sput...
ProAxsis (www.proaxsis.com) was delighted to observe that measuring active neutrophil elastase (NE) by ...